155 related articles for article (PubMed ID: 19295284)
1. [A case of PEP(BEP)-resistant ovarian dysgerminoma successfully treated by VeIP therapy].
Ishibashi M; Nakayama K; Oride A; Yeasmin S; Katagiri A; Iida K; Nakayama N; Miyazaki K
Gan To Kagaku Ryoho; 2009 Mar; 36(3):513-7. PubMed ID: 19295284
[TBL] [Abstract][Full Text] [Related]
2. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
[TBL] [Abstract][Full Text] [Related]
3. Ovarian dysgerminoma with massive metastases to para-aortic lymph nodes.
Takemori M; Ichimura T; Nishimura R; Hasegawa K
Gynecol Obstet Invest; 2000; 49(3):211-3. PubMed ID: 10729765
[TBL] [Abstract][Full Text] [Related]
4. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma.
Brewer M; Gershenson DM; Herzog CE; Mitchell MF; Silva EG; Wharton JT
J Clin Oncol; 1999 Sep; 17(9):2670-75. PubMed ID: 10561340
[TBL] [Abstract][Full Text] [Related]
5. [Adjuvant chemotherapy in dysgerminoma].
Fechtig A; de Dycker RP; Schumacher T; Neumann RL
Geburtshilfe Frauenheilkd; 1991 May; 51(5):398-400. PubMed ID: 1869011
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group.
Williams SD; Blessing JA; Hatch KD; Homesley HD
J Clin Oncol; 1991 Nov; 9(11):1950-5. PubMed ID: 1719142
[TBL] [Abstract][Full Text] [Related]
8. PVB chemotherapy in patients with recurrent or advanced dysgerminoma: a Phase II study of the EORTC Gynaecological Cancer Cooperative Group.
Pawinski A; Favalli G; Ploch E; Sahmoud T; van Oosterom AT; Pecorelli S
Clin Oncol (R Coll Radiol); 1998; 10(5):301-5. PubMed ID: 9848330
[TBL] [Abstract][Full Text] [Related]
9. Treatment of recurrent and persistent germ cell tumors with cisplatin, vinblastine, and bleomycin.
Jacobs AJ; Harris M; Deppe G; DasGupta I; Cohen CJ
Obstet Gynecol; 1982 Jan; 59(1):129-32. PubMed ID: 6176923
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
Grischke EM; Wallwiener D; Bastert G
Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of ovarian germ cell tumors.
Williams SD
Hematol Oncol Clin North Am; 1991 Dec; 5(6):1261-9. PubMed ID: 1663943
[TBL] [Abstract][Full Text] [Related]
12. Recent management of malignant ovarian germ cell tumors: a study of 34 cases.
Linasmita V; Srisupundit S; Wilailak S; Tangtrakul S; Israngura N; Bullangpoti S
J Obstet Gynaecol Res; 1999 Oct; 25(5):315-20. PubMed ID: 10533325
[TBL] [Abstract][Full Text] [Related]
13. [Successful pregnancy after conservative surgery and chemotherapy for dysgerminoma of the ovary: case report].
Studziński Z; Kaliński S; Filipczak A; Branicka D
Ginekol Pol; 1999 Aug; 70(8):553-7. PubMed ID: 10534934
[TBL] [Abstract][Full Text] [Related]
14. [BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors].
Mori Y; Shima H; Ihara H; Yabumoto H; Iwasaki A; Yoshioka M; Ikoma F
Hinyokika Kiyo; 1992 Oct; 38(10):1139-42. PubMed ID: 1282774
[TBL] [Abstract][Full Text] [Related]
15. [A case of bilateral germ cell tumor of the testis].
Saito M; Kondo A; Kinjo T
Hinyokika Kiyo; 1989 Nov; 35(11):1961-4. PubMed ID: 2482675
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of 129 patients with advanced and recurrent malignant ovarian germ cell tumor].
Hong W; Zhang R; Liu L
Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):35-7. PubMed ID: 10682456
[TBL] [Abstract][Full Text] [Related]
17. A VP16-213- and cisplatin-containing regimen for treatment of refractory ovarian germ cell malignancies.
Smith EB; Clarke-Pearson DL; Creasman WT
Am J Obstet Gynecol; 1984 Dec; 150(8):927-31. PubMed ID: 6542313
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy in the management of ovarian germ cell malignancies.
Schwartz PE
Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
[TBL] [Abstract][Full Text] [Related]
19. [Successful chemotherapy in undescended testicular and extragonadal germ cell tumors: report of 2 cases].
Imamura T; Unoki T; Tamura K; Seita M; Shibata K
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2658-62. PubMed ID: 2427033
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapeutic complete remission in patients with metastatic ovarian dysgerminoma. Potential for cure and preservation of reproductive capacity.
Gershenson DM; Wharton JT; Kline RC; Larson DM; Kavanagh JJ; Rutledge FN
Cancer; 1986 Dec; 58(12):2594-9. PubMed ID: 2430686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]